Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: The complexity of the problem

Infection Control and Hospital Epidemiology

Volumn 17, Issue 8, 1996, Pages 490-495

  Jarvis, William R ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG UTILIZATION; HUMAN; INFECTION CONTROL; MULTIDRUG RESISTANCE; REVIEW;

CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; DRUG UTILIZATION; HUMANS; INFECTION CONTROL;

EID: 0030202841     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141280     Document Type: Article

References (27)

1. Buckwold FJ, Ronald AR Antimicrobial misuse - effects and suggestions for control. J Antimicrob Chemother 1979;5:129- 136.
2. Fridkin SK, Pear SM, Williamson TH, Galgiani JN, Jarvis WR. The role of understaffing in central venous catheter-associated bloodstream infection. Infect Control Hosp Epidemiol 1996;17:150-158.
3. Haley RW, Hightower AW, Khabbaz RF, et al. The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals: possible role of the house staff-patient transfer circuit Ann Intern Med 1982;97:297-308.
4. Panlilio AL, Culver DH, Gaynes RP, et al. Methicillin-resistant Staphylococcus aureus in US hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992;13:582-586.
5. Sirot D, Sirot J, Labia R, et al. Transferable resistance to third generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. J Antimicrob Chemother 1987;20:323-324.
6. Bure A, Legrand P, Arlet G, Jarlier V, Paul G, Philippon A. Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harboring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. Eur J Clin Microbiol Infect Dis 1988;7:780-782.
7. Gutmann L, Ferre B, Goldstein FW, et al. SHV-5, a novel SHV- type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob Agents Chemother 1989;33:951-956.
8. Quinn JP, Miyashiro D, Sahm D, Flamm R, Bush K. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1989;33:1451-1456.
9. Rice LB, Wiley SH, Papanicolaou GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990;34:2193-2199.
10. Burwen DR, Banerjee SN, Gaynes RP, the National Nosocomial Infections Surveillance System. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. J Infect Dis 1994;170:1622-1625.
11. Coronado VG, Edwards JR, Culver DH, Gaynes RP, the National Nosocomial Infections Surveillance (NNIS) System. Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol 1995;16:71-75.
12. Centers for Disease Control and Prevention. Nosocomial ente rococci resistant to vancomycin: United States, 1989-1993. MMWR 1993;42:597-599.
13. Morris JG Jr, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med 1995;123:250-259.
14. Kunin CM. The responsibility of the infectious disease community for the optimal use of antimicrobial agents. J Infect Dis 1985;151:388-397.
15. Page CP, Bohnen JMA, Fletcher JR, McManus AT, Solomkin JS, Wittman DH. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical use. Arch Surg 1993;128:79-88.
16. Gorbach SL, Condon RE, Conte JE, Kaiser AB, Ledger WJ, Nichols RL. General guidelines for the evaluation of new anti- infective drug for prophylaxis of surgical infections. Evaluation of new anti-infective drugs for surgical prophylaxis. Clin Infect Dis 1992;15(suppl 1):S313-S338.
17. Counts GW. Review and control of antimicrobial usage in hospitalized patients: a recommended collaborative approach. JAMA 1977;238:2170-2172.
18. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995;16:105-113.
19. Williams RR, Gross PA, Levine JF. Cost containment of the second-generation cephalosporins by prospective monitoring at a community teaching hospital. Arch Intern Med 1985;145:1978- 1981.
20. Shah MM, Gidcomb M, Murphy KF. Antibiotic cost reduction (>50%) for selected diagnosis due to educational efforts compared to 27% cost increase for diagnosis without educational efforts in a community hospital without formulary restriction. Thirty-fifth annual meeting of the Interscience Conference for Antimicrobial Agents and Chemotherapy; September 17-20, 1995; San Francisco, CA. Abstract J91.
21. Lutwich L, DePaolo S, Smith R, et al. Antimicrobial (AB) control system (CS) effect on AB costs compared to the total phar macy budget, 1989-1994. Thirty-third annual meeting of the Infectious Diseases Society of America; September 16-18, 1995; San Francisco, CA. Abstract 151.
22. Roblin X, Gauzere BA, Lugagne N, Chan-Ou-Teung F, Graber D, Paganin F. Preliminary results of the use of a new type of prescription form (NPF) in reducing inappropriate use and antiinfective agents (AA) costs. Fourth International Conference on the Prevention of Infection; May 6-7, 1996; Nice, France. Abstract P605.
23. Soumerai SB, Avorn J, Taylor WC, Wessels M, Maher D, Hawley SL. Improving choice of prescribed antibiotics through concurrent reminders in an educational order form. Med Care 1993;31:552-558.
24. Soumerai SB, McLaughlin TJ, Avorn J. Quality assurance for drug prescribing. Qual Assur Health Care 1990;2:37-58.
25. Durbin WA Jr, Lapidas B, Goldmann DA. Improved antibiotic usage following introduction of a novel prescription system. JAMA 1981;246:1796-1800.
26. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996;275:234-240.
27. Department of Health and Human Services, Centers for Disease Control and Prevention. Draft guideline for isolation precautions in hospitals. Federal Register 1994;59:55552-55570.